Skip to main content
Mosaic Biodata

Estrogen Receptor Sensitivity

Same estrogen level, dramatically different response. High receptor sensitivity often underlies severe PMS, difficult perimenopause, or intense menopausal symptoms. It's not in your head—it's in your receptors.

What this measures

How your DNA shapes estrogen receptor sensitivity.

ESR1 (estrogen receptor alpha) and ESR2 (estrogen receptor beta) translate circulating estrogen into tissue-level effects. The two receptor subtypes have different distributions and different functions — ESR1 dominates in breast and uterine tissue, ESR2 in bone, cardiovascular, and immune tissue. Variants in each shape how strongly tissues respond to whatever estrogen is present.

Carriers of ESR1 reduced-sensitivity variants are associated with weaker estrogen-protective effects on bone, cardiovascular health, and mood — and may experience perimenopause and menopause symptoms more strongly at the same hormone levels. Carriers of ESR2 variants influence tissue-specific responses differently. Both men and women carry these receptors; both experience the variant effects.

Phytoestrogens (soy isoflavones, flaxseed lignans) interact with both receptor subtypes and can act as either weak agonists or selective modulators depending on tissue and variant pattern. Adequate vitamin D, vitamin K2, and magnesium all support estrogen's bone-protective effects. Exercise, particularly resistance training and weight-bearing activity, supplements estrogen's signaling in tissues like bone.

The same hormone replacement therapy or perimenopause experience produces different outcomes across women — and the receptor-sensitivity variant pattern is a major piece of why. Which ESR1/ESR2 combination you carry decides whether standard guidance is calibrated to your wiring or whether the dose, timing, or approach needs adjustment.

Estrogen Receptor Sensitivity is one specific finding in this system. Your Genomic Lifestyle Optimization Report shows where your variants place you on the hormone health spectrum — and what you can do about it.

In your report

Where Estrogen Receptor Sensitivity lives inside your Genomic Lifestyle Optimization Report.

Estrogen Receptor Sensitivity renders as a dark-background card with a color marker calibrated to your specific variants. The card opens with the gene mechanism, shows your result at a glance via that marker, and closes with a practical, mechanism-led recommendation — what to eat, what to time, what cofactors to support.

Want to see what a real Mosaic dark card looks like? Walk through a sample report →

In context

Sex Hormones: the 6-insight cluster.

Estrogen Receptor Sensitivity is one finding in a tightly-related cluster. Mosaic sequences the other 5 alongside it so you see the whole biology — not an isolated data point.

Questions people ask

About Estrogen Receptor Sensitivity.

How does my DNA influence estrogen receptor sensitivity?
The DIO2 thyroid-conversion enzyme that turns inactive T4 into active T3. The COMT and CYP1A1 enzymes that move estrogen through Phase I detox. The SHBG variants that bind or release testosterone. The CYP17A1 and HSD3B2 nodes in the steroid synthesis cascade. Your "normal" labs may sit on top of a genome that needs a different intervention.
What kind of test do I need to see my Estrogen Receptor Sensitivity result?
Whole-genome sequencing at 30× clinical depth. Consumer SNP-chip tests like 23andMe or AncestryDNA only read ~0.02% of your DNA and miss most of the variants this analysis needs. Mosaic reads all 3 billion base pairs and produces the full 108-insight report.
How is Estrogen Receptor Sensitivity different from clinical lab testing?
Clinical labs measure downstream biomarkers — blood levels, hormone values, metabolic byproducts — at a single point in time. Genomic insights like Estrogen Receptor Sensitivity reveal the underlying variant that shapes the biology, which is constant for life. The two are complementary: labs show the current snapshot; genomics shows the long-term tendency and where lifestyle leverage is highest.

More from Hormone Health

hormone health

Autoimmune Thyroid Risk

Genetic predisposition to Hashimoto's or Graves' varies widely. If you're in the higher-risk group, early antibody monitoring can catch the process years before full disease expression—when lifestyle interventions still have leverage.

Read insight →

hormone health

Cortisol Production

Some people run naturally high on cortisol; others trend low. Neither is inherently bad—but each benefits from different stress-management strategies. High producers need more active recovery; low producers may need adaptogen support. One-size-fits-all stress advice ignores this completely.

Read insight →

hormone health

Cortisol Receptor Sensitivity

Same cortisol level, very different felt experience. High receptor sensitivity means stress hits harder even when cortisol is "normal." This explains why some people thrive in chaos while others burn out—and it's not about being weak. It's about wiring.

Read insight →

hormone health

DIO1 Activity

DIO1 handles the body-wide conversion of inactive T4 into active T3. Reduced activity is a common reason for persistent hypothyroid symptoms—fatigue, weight gain, cold intolerance—even when TSH looks "normal." Standard testing misses this entirely.

Read insight →

hormone health

DIO2 Activity

DIO2 produces T3 specifically in the brain and muscles. Low activity is one of the most common causes of brain fog and cold hands on standard thyroid treatment that looks fine on paper. If your labs are normal but you still feel terrible, this is often why.

Read insight →

hormone health

Dihydrotestosterone (DHT) Levels

DHT is the more potent downstream product of testosterone. High converters may see effects on hair loss, prostate health, or skin—and often benefit from DHT-blocking strategies before symptoms become problems. Low converters rarely need to worry about it.

Read insight →
See yours

One test. 108 personalized findings. All yours.

Order your Mosaic kit. Receive your raw genomic data and the full Genomic Lifestyle Optimization Report in 15–20 days.